Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

C17orf37 Antikörper

C17orf37 Reaktivität: Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7073498
  • Target Alle C17orf37 Antikörper anzeigen
    C17orf37 (Chromosome 17 Open Reading Frame 37 (C17orf37))
    Reaktivität
    • 53
    • 29
    • 27
    • 3
    • 1
    • 1
    Maus, Ratte
    Wirt
    • 42
    • 11
    Kaninchen
    Klonalität
    • 44
    • 9
    Polyklonal
    Konjugat
    • 23
    • 6
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser C17orf37 Antikörper ist unkonjugiert
    Applikation
    • 26
    • 18
    • 13
    • 10
    • 7
    • 4
    • 3
    • 2
    Western Blotting (WB)
    Kreuzreaktivität
    Ratte
    Aufreinigung
    Affinity purification
    Immunogen
    Recombinant protein corresponding to Mouse XTP4
    Top Product
    Discover our top product C17orf37 Primärantikörper
  • Applikationshinweise
    WB (M,R) 1:200-1:500
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS, pH 7.4, 0.02 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
  • Target
    C17orf37 (Chromosome 17 Open Reading Frame 37 (C17orf37))
    Andere Bezeichnung
    XTP4 (C17orf37 Produkte)
    Synonyme
    C17orf37 antikoerper, C35 antikoerper, ORB3 antikoerper, RDX12 antikoerper, XTP4 antikoerper, C19H17orf37 antikoerper, 1810046J19Rik antikoerper, AI463380 antikoerper, Rdx12 antikoerper, migration and invasion enhancer 1 antikoerper, migration and invasion enhancer 1 S homeolog antikoerper, mien1 antikoerper, mien1.S antikoerper, MIEN1 antikoerper, Mien1 antikoerper
    Hintergrund
    During the past decade, the role of the ERBB2(neu/HER2) oncogene as an important predictor of patient outcome and response to various therapies in breast cancer has been clearly established. The C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Identification of shared tumor-specific targets is useful in developing broadly applicable therapies. The C35 gene is located on chromosome 17q12, 505nucleotides from the 3' end of the ERBB2oncogene, the antigenic target for trastuzumab(Herceptin) therapy. The chromosomal arrangement of the genes encoding C35 andERBB2 is tail to tail.
    Molekulargewicht
    12 kDa
    Gen-ID
    103742
    NCBI Accession
    NP_079835
    UniProt
    Q9CQ86
    Pathways
    Cell RedoxHomeostasis
Sie sind hier:
Kundenservice